Floatz logo

Quadrivalent Inactivated Influenza Vaccine

Viral Vaccines

University of PennsylvaniavaccinePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Viral Vaccines cohort.

Asset / SponsorPhaseRating
HEPATITIS C IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
Biotest Pharmaceuticals Corporation
Phase 3BB
Metformin
Oxford University Clinical Research Unit, Vietnam
Phase 1/2CCC
Primepro™/ Primemsk™
Thomas Advanced Medical LLC
Phase 1/2CCC
G 207
M.D. Anderson Cancer Center
Phase 1CC
Sodium Chloride
University of Edinburgh
N/AD

Same molecule, other indications

Quadrivalent Inactivated Influenza Vaccine is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
69 / 100
View asset →
lung cancerDormant
CCC
Indicative ·
51 / 100
View asset →
prostate cancerDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →